Varicella-Zoster Virus Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Recommendations of the ACIP for Use of Herpes Zoster Vaccines Recommendations of the ACIP for Use of Herpes Zoster Vaccines
This report updates recommendations for herpes zoster vaccine in light of the newly approved recombinant Zoster Vaccine, Shingrix.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 16, 2018 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Shingrix: Is the Hype Justified? Shingrix: Is the Hype Justified?
Dr Paul Offit compares Shingrix with Zostavax ® and lays out the recommendations for the new vaccine.Medscape Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 13, 2018 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news

Slow Medicine: Omega-3s, Zoster Vaccination, and Bariatric Surgery
(MedPage Today) -- Thoughtful review of hot-button topics in the news (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 9, 2018 Category: Cardiology Source Type: news

Long-term Effectiveness of the Live Zoster Vaccine Long-term Effectiveness of the Live Zoster Vaccine
A live attenuated zoster vaccine for the prevention of shingles has been licensed for older adults in the US since 2006. How effective has it been over the long-term, and does efficacy differ by age?American Journal of Epidemiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 7, 2018 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

CHMP Backs Shingles Vaccine Shingrix for Adults 50 and Older CHMP Backs Shingles Vaccine Shingrix for Adults 50 and Older
The European Medicines Agency ' s CHMP voted to grant marketing authorization for the Shingrix vaccine to prevent herpes zoster and postherpetic neuralgia.International Approvals (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 26, 2018 Category: Internal Medicine Tags: Infectious Diseases News Alert Source Type: news

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 25, 2018 Category: American Health Source Type: news

Newer Shingles Vaccine Cheaper, More Effective Newer Shingles Vaccine Cheaper, More Effective
A novel adjuvanted herpes zoster vaccine is likely to be more effective and cheaper than the live attenuated herpes zoster vaccine, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 3, 2018 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

New Herpes Zoster Subunit Vaccine Cost-Effective
The new two-dose, adjuvanted herpes zoster subunit vaccine, approved in 2017, is cost-effective when compared with the live attenuated vaccine or with no... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 3, 2018 Category: Primary Care Source Type: news

Safety of Herpes Zoster Vaccine for IBD Patients on Anti-TNFs Safety of Herpes Zoster Vaccine for IBD Patients on Anti-TNFs
Is it safe to give herpes zoster vaccine while patients are on anti-TNF therapy?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

ACIP Recommends New Herpes Zoster Subunit Vaccine
The Advisory Committee on Immunization Practices is recommending preferential use of a new herpes zoster subunit (HZ/su; Shingrix) vaccine over currently available herpes zoster live (Zostavax) vaccine for adults ages 50 and older. (Source: AAFP News)
Source: AAFP News - October 31, 2017 Category: Primary Care Source Type: news

Shingrix (Zoster Vaccine Recombinant, Adjuvanted Suspension for Intramuscular Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 30, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves New Shingles Vaccine That Is More Than 90% Effective
BOSTON (CBS) – There’s a new shingles vaccine in town. Shingrix was approved by the FDA last week, and a CDC advisory panel just voted to recommend it for patients 50 and older. It is given as two injections two to six months apart, and in studies the vaccine was found to be more than 90% effective. Shingrix is not the only shingles vaccine available. Zostavax has been around for more than a decade, but it may not be as effective as this new vaccine, especially in older patients. Vaccine experts are not only recommending the new vaccine for people who have never been vaccinated but say that people who got the old ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 26, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Dr. Mallika Marshall Shingles Source Type: news

CDC Advisers Recommend New Herpes Zoster Vaccine over Zostavax (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The CDC ' s Advisory Committee on Immunization Practices voted on Wednesday to recommend use of the newly approved herpes zoster vaccine, Shingrix.The non-live, recombinant subunit, two-dosevaccine … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 26, 2017 Category: Primary Care Source Type: news

CDC Advisers Recommend New Herpes Zoster Vaccine over Zostavax (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The CDC ' s Advisory Committee on Immunization Practices voted on Wednesday to recommend use of the newly approved herpes zoster vaccine, Shingrix.The inactivated, recombinant subunit, two-dosevaccine … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 26, 2017 Category: Primary Care Source Type: news

ACIP Narrowly Recommends Shingrix for Shingles Over Zostavax ACIP Narrowly Recommends Shingrix for Shingles Over Zostavax
As a whole, the CDC panel is sold on the new recombinant vaccine to prevent herpes zoster, but some members want more safety data before they endorse it over Zostavax.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 25, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news